진세노인 A를 함유하는 보습용 조성물
    61.
    发明公开
    진세노인 A를 함유하는 보습용 조성물 审中-实审
    用于滋润含有金丝雀的皮肤的组合物A

    公开(公告)号:KR1020160064406A

    公开(公告)日:2016-06-08

    申请号:KR1020140167975

    申请日:2014-11-28

    CPC classification number: A61K8/49 A61K8/4906 A61Q19/00

    Abstract: 본발명은보습용조성물에관한것으로, 보다상세하게는진세노인 A를유효성분으로함유하여손상된피부장벽기능을회복시키고피부보습력을증가시키는효과가우수한조성물에관한것이다.

    Abstract translation: 本发明涉及一种用于皮肤保湿的组合物,更具体地说,涉及通过含有人参炔A作为活性成分,具有恢复受损皮肤屏障功能和增加皮肤保湿能力的优异效果的组合物。 用于皮肤保湿的组合物含有由化学式1表示的人参炔A作为活性成分。

    효소처리 타나까 추출물을 함유하는 조성물
    63.
    发明公开
    효소처리 타나까 추출물을 함유하는 조성물 审中-实审
    含有精制THANAKHA提取物的组合物

    公开(公告)号:KR1020140117168A

    公开(公告)日:2014-10-07

    申请号:KR1020130032264

    申请日:2013-03-26

    CPC classification number: A61K8/97 A61K36/75 A61K2236/00 A61Q19/02 A61Q19/08

    Abstract: The present invention relates to a composition including thanakha extracts processed with an enzyme. Specifically, provided is usage of anti-aging, antioxidant, skin whitening, etc. effects of the thanakha extract. More specifically, provided in the present invention is a composition for lifting wrinkles or inhibiting or preventing the same, promoting skin elasticity, anti-aging, antioxidant and skin whitening effects including thanakha extracts processed with enzyme as an active ingredient.The thanakha extracts processed with enzyme is characterized by having an excellent antioxidant effect.

    Abstract translation: 本发明涉及一种组合物,其包含用酶处理的不同的提取物。 具体来说,提供了抗酸,抗氧化,皮肤美白等的用途。 更具体地说,本发明提供了一种用于提升皱纹或抑制或防止皱纹的组合物,促进皮肤弹性,抗衰老,抗氧化和皮肤美白效果,包括用酶作为活性成分处理的胡萝卜提取物。 酶的特征在于具有优异的抗氧化作用。

    카나비노이드 1 수용체 저해제로 작용하는 신규 화합물
    64.
    发明公开
    카나비노이드 1 수용체 저해제로 작용하는 신규 화합물 审中-实审
    新型化合物作为CANNABINOID受体-1抑制剂

    公开(公告)号:KR1020130099930A

    公开(公告)日:2013-09-06

    申请号:KR1020137005744

    申请日:2011-08-31

    CPC classification number: C07D487/04 A61K31/519

    Abstract: PURPOSE: A novel compound is provided to prevent or treat diseases mediated by a cannabinoid 1 receptor. CONSTITUTION: A compound of chemical formula 1 or a prodrug, an isomer, a pharmaceutically acceptable salt, a hydrate, or a solvate thereof is provided. A pharmaceutical composition contains the compound of chemical formula 1, the prodrug, the isomer, the pharmaceutically acceptable salt, the hydrate, or the solvate thereof. The pharmaceutical composition is used for preventing or treating diseases mediated by cannabinoid 1 receptor. The diseases medicated by cannabinoid 1 receptor are obesity.

    Abstract translation: 目的:提供一种新型化合物,用于预防或治疗由大麻素1受体介导的疾病。 构成:提供化学式1化合物或其前体药物,异构体,药学上可接受的盐,水合物或溶剂合物。 药物组合物含有化学式1的化合物,前药,异构体,药学上可接受的盐,水合物或其溶剂化物。 药物组合物用于预防或治疗由大麻素1受体介导的疾病。 由大麻素1受体引起的疾病是肥胖。

    피부 미백용 조성물
    65.
    发明公开
    피부 미백용 조성물 审中-实审
    皮肤白化成分

    公开(公告)号:KR1020130043889A

    公开(公告)日:2013-05-02

    申请号:KR1020110108051

    申请日:2011-10-21

    Abstract: PURPOSE: A composition for skin whitening is provided to show pigmentation suppression, and to have an excellent skin whitening effect by having a deterrent effect on tyrosinase which is an apoenzyme of melanogenesis and by containing an extract of acanthopanax. CONSTITUTION: A composition for skin whitening comprises an enzymatically treated extract of acanthopanax as an active ingredient. Acanthopanax is more than one of species selected from the group of Acanthopanax senticosus, Eleutherococcus senticocus, Acanthopanax senticosus for. Inermis, Acanthopanax sessilitlorus, Eleutherococcus divaricatus var. chiisanensis, Acanthopanax seoulense, Eleutherococcus divaricatus, Eleutherococcus gracilistylus, and Acanthopanax siebololianum. An enzyme is a cell wall degrading enzyme or proteinase. The cell wall degrading enzyme comprises cellulose. The proteinase comprises pectinase. The cellulase comprises celluclast. [Reference numerals] (AA) Voltage[mV]; (BB) Time(minutes)

    Abstract translation: 目的:提供用于皮肤美白的组合物,以显示色素沉着抑制,并且通过对作为黑素生成的脱辅基酶的酪氨酸酶具有阻止作用并且含有刺五加的提取物具有优异的皮肤美白效果。 构成:用于皮肤美白的组合物包含酶处理的刺五加的提取物作为活性成分。 刺五加是从刺五加,Eleutherococcus senticocus,Acanthopanax senticosus中选出的一种以上的物种。 Inermis,Acanthopanax sessilitlorus,Eleutherococcus divaricatus var。 刺五加,刺五加,Eleutherococcus divaricatus,Eleutherococcus gracilistylus和Acanthopanax siebololianum。 酶是细胞壁降解酶或蛋白酶。 细胞壁降解酶包括纤维素。 蛋白酶包括果胶酶。 纤维素酶包括celluclast。 (标号)(AA)电压[mV]; (BB)时间(分钟)

    물푸레나무 추출물의 발효물을 포함하는 피부 미백용 조성물
    66.
    发明公开
    물푸레나무 추출물의 발효물을 포함하는 피부 미백용 조성물 无效
    用于皮肤刺激的组合物,用于生产FRAXINUS RHYNCHOPHYLLA HANCE的发酵提取物

    公开(公告)号:KR1020130003171A

    公开(公告)日:2013-01-09

    申请号:KR1020110064294

    申请日:2011-06-30

    Abstract: PURPOSE: A composition containing a fermentation of a Fraxinus rhynchophylla Hance extract is provided to suppress tyrosinase activation and melanogenesis and to ensure excellent skin whitening effect. CONSTITUTION: A composition for skin whitening contains 0.001-20 wt% of a fermentation of a Fraxinus rhynchophylla Hance as an active ingredient. The extract is prepared using water, an organic solvent, or a mixture thereof. The fermentation is preparing by fermenting the extract with yeast such as Saccaromyces sp., Schizosaccharomyces sp., Torulopsis sp., Rhodotorula sp., or Candida ap. The composition is a cosmetic or pharmaceutical composition.

    Abstract translation: 目的:提供含有Fraxinus rhynchophylla Hance提取物发酵的组合物,以抑制酪氨酸酶活化和黑素生成,并确保优异的皮肤美白效果。 构成:用于皮肤美白的组合物含有作为活性成分的Fraxinus rhynchophylla Hance的发酵量的0.001-20重量%。 提取物是用水,有机溶剂或其混合物制备的。 发酵是通过用酵母如Saccaromyces sp。,粟酒裂殖酵母属(Saccharomyces sp。),Torulopsis sp。,红酵母属(Rhodotorula sp。)或假丝酵母(Candida ap)发酵提取物制备的。 组合物是化妆品或药物组合物。

Patent Agency Ranking